We recognize the changes in how people access digital content and new opportunities for discussion on important topics in Oncology. Social media has b

   
CO-Header-new

We recognize the changes in how people access digital content and new opportunities for discussion on important topics in Oncology. Social media has become an important platform to the scholarly community to share, converse, research and stay informed.

In February 2016, we expanded our Twitter efforts, and launched a campaign with the following goals:

• Increase our engagement with the Canadian oncology community, including professionals and organizations
• Engage authors by giving them the ability to promote their work through social media
• Extend the reach of the journal’s content, as well as helping core readership stay up to date with new developments within the field

Our campaign has been successful to date, and we have seen an increase in our social media presence, as exemplified by the following stats:

CO tweet graphics

We will continue to expand our social media efforts, and invite you to engage with us and stay up to date with journal content, professional news, cancer advances, and much more – follow @CurrentOncology.

logo70

Multimed Inc.
Publisher of Current Oncology
www.multi-med.com

***
ImpactFactor2015
***
Hot-off-the-Press

Volume 23, Number 4 (August 2016)

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from this issue:
http://www.current-oncology.com/index.php/oncology/issue/current/showToc

***
Looking-Ahead

Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 23, Number 5 (October 2016) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:
http://www.current-oncology.com/index.php/oncology/about/futureTOC

***
COTwiiterPageShot
 
twitter banner e-newsletter
***
Editorial-Spotlight
WP picture

Wendy Parulekar, MD, FRCP(C)
Editor of our Clinical Trials Section (since June 2013)

Wendy Parulekar is a Senior Investigator at the internationally recognized research organization, the Canadian Cancer Trials Group. She completed medical school and residency training at the University of Ottawa followed by a fellowship in clinical pharmacology at the University of Toronto. Since 1999, she has held a joint research/clinical appointment at Queen’s University where she supervises the development and conduct of national and international trials involving breast, head and neck, gynaecological and genitourinary malignancies. She participates in numerous national and international scientific advisory committees and is an associate editor for the journal Clinical Trials and section editor for Current Oncology. She has been inducted as a Fellow of the Society for Clinical Trials and served as President in 2015-2016. Her research interests relate to the integration of clinical trials in patient care delivery systems and understanding the role of clinical trials in evidence based practice.

***
Have-You-Heard

Are you a Reviewer for Current Oncology? Time to Update your Account.

We request that all reviewers update their profile frequently to ensure the system is up to date with their contact information and reviewing interests. Keeping your reviewing interests up to date will ensure that you are being matched to manuscripts based on your expertise, and also improve your chances of being invited to review a manuscript. To update your reviewing interests, please visit http://current-oncology.com/index.php/oncology/pages/view/reviewers#update. IMPORTANT NOTE: For reviewers who have not entered reviewing interests, we ask that you login to your account and add your interests by no later than October 31, 2016. After this date, reviewers without reviewing interests provided, will be removed from our database.

Attention Authors: Proper Reference Lists are as Important as Good Science

Are you currently preparing a manuscript for submission for Current Oncology? We encourage you to review our manuscript preparation guidelines and examples to ensure that your references are completed to meet journal standards. Articles that contain references that are not close to the correct format will be sent back to authors for correction, which will result in the delay of publication of your article. For examples of common author reference errors, please click here.

Canadian Oncology Members: Promote your Work through @CurrentOncology

Are you presenting your Canadian study or results at a major Canadian or International Conference? Please let us know so we can help keep members of the Canadian oncology community updated on ongoing work of their peers through twitter. We encourage you to send details of the meeting and presentation topic to current_oncology@multi-med.com, so we can help spread the word.

Current Oncology Partners with Meetings across Canada

As Canada’s premier Oncology journal, we invite Oncology meetings, symposiums and conferences, from across Canada to partner with Current Oncology through a marketing exchange. The journal provides an excellent venue and opportunity to increase the visibility of your meeting to members of the Canadian oncology community. For further information about marketing exchange opportunities with Current Oncology please view our “Current Oncology Marketing Exchange Opportunities” information package, or contact Laura Hope.

***
Readers-Choice

Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (July 2016)

Impact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age
Narod S., Sun P., Wall C., Baines C., Miller A.B.
Curr Oncol. 2014 Oct; 21(5): 217–221

Anticancer mechanisms of cannabinoids
Velasco G., Sánchez C., Guzmán M.
Curr Oncol. 2016 Mar; 23(Suppl 2): S23–S32

Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls
Pereira J.
Curr Oncol. 2011 Apr;18(2):e38-45

Most Read Recently* Published Articles at www.current-oncology.com

Anticancer mechanisms of cannabinoids
Velasco G, Sánchez C, Guzmán M
Curr Oncol. 2016 Mar;23(Suppl 2):S23-32. doi: 10.3747/co.23.3080. Epub 2016 Mar 16.

Use of cannabinoids in cancer care: palliative care
Aggarwal SK.
Curr Oncol. 2016 Mar;23(Suppl 2):S33-6. doi: 10.3747/co.23.2962. Epub 2016 Mar 16.

Integrating cannabis into clinical cancer care
D.I. Abrams
Curr Oncol. 2016 Mar;23(Suppl 2):S8-14. doi: 10.3747/co.23.3099. Epub 2016 Mar 16.

*Published within past 12 months

***
Meeting-Alerts

STAND UP TO CANCER

Featuring performances from top recording artists, and celebrities from film, television and sports, STAND UP TO CANCER will appeal to the Canadian public for support and donations to fund cutting-edge cancer research. The star-studded LIVE telecast, executive-produced by Bradley Cooper, will deliver an unforgettable event by engaging viewers with powerful patient stories and a moving call-to-action.

STAND UP TO CANCER airs Friday, Sept. 9. Learn more at www.standup2cancer.ca

***
300 x 80px-01
TessaRichards

“Therapeutic Relationships”—prized but hard to deliver
We know that empathy and support from a doctor with whom one has a trusting, ongoing relationship is important to patients. We also know that healthcare organisations don’t or can’t prioritise it. Read more
by Dr Tessa Richards, senior editor, BMJ Patient Partnership. Dr. Richards’ current professional interest in patient partnership has been advanced by undergoing treatment for stage 1V adrenal cancer.

***
Quick-Links
***

Contact Us

Email-CON
 
Address-CON
 
Phone-CON
 
Web-CON
twitter
1px